Close Menu

In a paper published online in advance in Nucleic Acids Research this week, investigators at Sloan-Kettering and Weill Cornell Medical College show that the activity of Nam8, a yeast U1 snRNP component that "collaborates with Mer1 to promote splicing of essential meiotic mRNAs," is weakened by "mutations in the putative RNA binding site of the RRM2 and RRM3 domains." More specifically, the team says SPO22 and PCH2 are targets of Nam8-dependent meiotic splicing; the researchers als

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.